DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the secur
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
- REalloys Inc. (Nasdaq: ALOY) Announces Private Placement of Common Stock for Gross Proceeds of Approximately $100 Million
EUCLID, Ohio, June 24, 2026 (GLOBE NEWSWIRE) -- REalloys Inc. (NASDAQ:ALOY) ("REalloys" or the "Company"), a U.S.-based mine-to-magnet rare earth company, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of common stock resulting in aggregate gross proceeds of approximately $100 million. The offering is expected to close on or about June 26, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. Clear Street LLC is acting as the sole placement agent for the offering. Haynes and Boone,
- Guest Supply Signs Asia-Pacific Licensing Agreement with RODA
HONG KONG, June 25, 2026 (GLOBE NEWSWIRE) -- Guest Supply today announced a licensing agreement with RODA to manufacture and distribute RODA-branded skincare and personal care products across Asia Pacific for the hotel sector. The agreement combines Guest Supply’s hospitality manufacturing, distribution and service capabilities with RODA’s clinically formulated approach to skin and hair care. Created in Barcelona, RODA develops products with sensitive skin in mind and designs its formulas to be suitable for all skin types. RODA combines natural active ingredients with advanced research, technology and a sustainability-led approach. Its development model draws on ingredient analysis, scie
- Cardinal Infrastructure Group Announces Pricing of Upsized Public Offering
RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (NASDAQ:CDNL) today announced the pricing of an upsized underwritten public offering of 4,000,000 shares of its Class A common stock at a price to the public of $73.00 per share, for total gross proceeds of approximately $292 million, before underwriting discounts, commissions and other offering expenses. Cardinal has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of Class A common stock. The offering is expected to close on June 26, 2026, subject to customary closing conditions.
- UL Solutions Opens Advanced Automotive Electromagnetic Compatibility Laboratory in Japan
The new Automotive Technology and Innovation Center expands automotive EMC testing in a top global automotive manufacturing hub to support increasingly complex vehicle technologies. Expands testing in Japan, the world’s third-largest automotive producer, with more than 8 million vehicles manufactured annually Boosts EMC testing for high-voltage, high-current, high-performance next-generation vehicles Strengthens support for automakers and their suppliers in a key global manufacturing hub UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the opening of a new automotive electromagnetic compatibility laboratory in Toyota City, Japan, expandi
- Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility
Optimized capital structure, retiring short-term maturing debt Well-funded for commercial operations and growth pipeline NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it drew down US$50 million from its five-year facility provided by existing Mesoblast shareholder and director Dr. Gregory George. Mesoblast had US$122 million cash at March 30, 2026. In aggregate Mesoblast is well funded to invest in its commercial operations and growth pipeline, and optimize its capital structure by retiring the higher cost NovaQuest Capital Management LLC debt facility
- L'OFFICIEL AMTD IDEA Sets 2026 Launch for L'OFFICIEL Taiwan and L'OFFICIEL 时装 Singapore
PARIS and NEW YORK and LONDON, June 24, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group ("AMTD IDEA")(NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. ("AMTD Digital") (NYSE:HKD) and The Generation Essentials Group ("TGE") (NYSE:TGE, LSE: TGE)), a subsidiary of AMTD Digital Inc., jointly announce that L'OFFICIEL AMTD IDEA will launch L'OFFICIEL Taiwan and L'OFFICIEL 时装Singapore in 2026. L'OFFICIEL AMTD IDEA, a leading global fashion media brand, has executed a clear expansion strategy in recent years, entering emerging cities and reaching many new markets. It has invested significantly in both its core media business and IP verticals such as L'OFFICIEL COFFEE and L'OFFICIEL BAR
- NANO Nuclear Highlights Global Strategic Engagements Across Emerging Nuclear Markets and Management Team Updates
New York, N.Y., June 24, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today announced recent and upcoming high-profile engagements with government officials, industry leaders, multilateral organizations, and energy stakeholders across Asia, Africa, Latin America, and the Caribbean as well as a management team update. Global Strategic Engagements Across Emerging Nuclear Markets As part of NANO Nuclear’s efforts to build key relationships, knowledge base, and market presence necessary to support future reactor deployment
- Silvercorp Announces Filing of Updated Technical Reports
Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 24, 2026 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX:SVM) (NYSE:SVM) announces that, further to its news release dated June 23, 2026 (the "Release"), it has filed an updated Technical Report ("GC Technical Report") titled "Technical Report on Gaocheng Silver-Lead-Zinc Project in Guangdong Province, China for the Gaocheng Mine", prepared in accordance with National Instrument 43‑101 Standards of Disclosure for Mineral Projects ("NI 43-101") by SRK Consulting China Ltd ("SRK") with a Mineral Reserve and Mineral Resource dated effective December 31, 2025. The Gaocheng underground Ag-Pb-Zn mine is located in Guangd
- ALLEGIANT TRAVEL COMPANY ISSUES SENIOR SECURED NOTES
LAS VEGAS, June 24, 2026 /PRNewswire/ -- Allegiant Travel Company (NASDAQ:ALGT) (the "Company," "we," "us," or "our") announced today that it issued $650.0 million in aggregate principal amount of its 7.125% Senior Secured Notes due 2031 (the "Notes") upon closing of its previously announced private offering. Each of the Company's subsidiaries, other than Dustland, LLC and certain other insignificant subsidiaries, have guaranteed the Notes (the "Guarantors"). The Notes and the related guarantees are secured by security interests in substantially all of the property and assets of the Company and the Guarantors, excluding aircra
- HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026
— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control — — Fanregratinib holds promise as a new treatment option for pretreated advanced ICC patients harboring FGFR2-fusions/rearrangements — HONG KONG and FLORHAM PARK, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces results from the pivotal Phase II registration study of fanregratinib (HMPL-453) in patients with intrahepatic cholangiocarcinoma ("ICC") will be presented at the European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress taking place from July 1 to 4, 2026
- Enerflex Ltd. Announces Extension of Revolving Credit Facility and Timing of Second Quarter Financial and Operational Results
All amounts presented in this release are in U.S. Dollar ("USD") unless otherwise stated. CALGARY, Alberta, June 24, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX:EFX) (NYSE:EFXT) ("Enerflex" or the "Company") is pleased to announce that the Company has entered into an amended and restated credit agreement dated June 24, 2026 with respect to its syndicated secured revolving credit facility (the "RCF"). The maturity date of the RCF has been extended by three years to June 30, 2029 and availability is unchanged at $800 million. The Company's limit under the RCF may be increased by up to $200 million at the request of the Company, subject to lenders’ consent, compared to $50 million previously
- Revolution Medicines to Present Clinical Data from RAS(ON) Inhibitor Combination Trials in Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
REDWOOD CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that four oral and poster presentations highlighting data from its RAS(ON) pipeline will be featured at the 2026 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress, taking place July 1–4, 2026 in Munich, Germany. The program will include two oral presentations from Phase 1/2 trials evaluating zoldonrasib, an oral RAS(ON) G12D-selective covalent inhibitor, in combination regimens for patients with metastatic RAS G12D pancreatic ductal adenocarcinoma (PDAC). These
- Western Union and Intermex Provide an Update on Pending Acquisition of Intermex
DENVER and MIAMI, June 24, 2026 (GLOBE NEWSWIRE) -- The Western Union Company ("Western Union") (NYSE:WU) and International Money Express, Inc. ("Intermex") (NASDAQ:IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to
- WM Technology, Inc. Announced Adjournment of 2026 Annual Meeting of Stockholders
WM Technology, Inc. ("WM Technology" or the "Company") (OTC:MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced that the Company’s 2026 Annual Meeting of Stockholders (the "Annual Meeting") held in virtual form on Wednesday, June 24, 2026 at 10:00 a.m. Pacific Time, was convened and adjourned until Thursday July 16, 2026 at 10:00 a.m. Pacific Time without any business being conducted. The Company adjourned the Annual Meeting for the purpose of allowing additional time for stockholders to vote on the proposal to amend the Company’s Certificate of Incorporation to declassify the Board of Directors of the Company (the "Board") and to provide
- Western Union and Intermex Provide an Update on Pending Acquisition of Intermex
The Western Union Company ("Western Union") (NYSE:WU) and International Money Express, Inc. ("Intermex") (NASDAQ:IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to obtain the final regulatory approval. Western Union
- Taseko Annual General Meeting Voting Results and Change of Name
VANCOUVER, British Columbia, June 24, 2026 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX:TKO, NYSE:TGB, LSE: TKO)) ("Taseko" or the "Company") announces the voting results from its 2026 Annual General Meeting held Wednesday, June 24, 2026 in Vancouver, British Columbia. The Company also announces that shareholders approved the change of the Company’s name to Trekor Metals Limited. The name change will become legally effective on June 25, 2026. A total of 216,723,190 common shares were voted at the meeting, representing 59.3% of the votes attached to all outstanding common shares. Shareholders voted in favour of all items of business before the meeting, including the Ordinary Resolutions
- Schneider appoints manufacturing leader Austin Ramirez to Board of Directors
Schneider National, Inc. (NYSE:SNDR), a premier multimodal provider of transportation, intermodal and logistics services, announced the appointment of Austin Ramirez to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260623496826/en/Austin Ramirez Ramirez serves as CEO of Wisconsin-based Husco, a global engineering and manufacturing company specializing in hydraulic and electro-mechanical systems for automotive and off-highway applications. Under his leadership, Husco has tripled in size to more than $600 million in global sales and earned recognition as a World Economic Forum Global Growth Company. Rami
- Seabridge Gold Reports on Results of Annual Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - June 24, 2026) - Seabridge Gold Inc. (TSX:SEA) (NYSE:SA) (the "Company") today provided the voting results of its annual general meeting of shareholders held on June 24, 2026. A total of 63,228, 532 common shares were represented at the meeting, representing 58.75% of the issued and outstanding common shares of the Company on the record date. All matters presented for approval at the meeting were duly authorized and approved, as follows:Election of all of management's nominees to the board of directors of the Company; DirectorVotes ForVotes AgainstPercentage ForTrace J. Arlaud44,453,678 412,40499.08%Matthew Coon Come44,399,730 466,35198.96%Rudi P. Fronk43,
- Neugebauer Highly Confident Tenant Will Be Announced Soon
We have so many choices – let's choose the best one Assuming it's the same group Neugebauer told market they were contracting on the earnings call before Toby was terminated, the family likes that tenant group a lot.Proxy is not about can Fermi get a tenant;Proxy is about restoring normal governance, And evaluating all potential strategic full value transactions,To ensure the best risk-adjusted outcome for all shareholders, employees, and the people of the Texas PanhandleDALLAS, June 24, 2026 /PRNewswire/ -- Toby Neugebauer, co-founder and largest individual shareholder of Fermi Inc. (NASDAQ:FRMI), today issued the following letter about his solicitation for shareholders to call a Special Me